Cargando…
Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm
Autores principales: | González-Nicolás, María Ángeles, González-Guerrero, Cristian, Pérez-Fernández, Verónica Astrid, Lázaro, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543365/ https://www.ncbi.nlm.nih.gov/pubmed/33117530 http://dx.doi.org/10.1093/ckj/sfaa193 |
Ejemplares similares
-
FKBP51, AmotL2 and IQGAP1 Involvement in Cilastatin Prevention of Cisplatin-Induced Tubular Nephrotoxicity in Rats
por: González-Fernández, Rebeca, et al.
Publicado: (2022) -
Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity
por: Humanes, Blanca, et al.
Publicado: (2015) -
Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy
por: Zaballos, Matilde, et al.
Publicado: (2021) -
Nephroprotective Effect of Cilastatin against Gentamicin-Induced Renal Injury In Vitro and In Vivo without Altering Its Bactericidal Efficiency
por: Jado, Juan Carlos, et al.
Publicado: (2020) -
Association between the cytokine storm, immune cell dynamics, and viral replicative capacity in hyperacute HIV infection
por: Muema, Daniel M., et al.
Publicado: (2020)